**Zoetis** ZTS, has been underperforming the market despite a flurry of activity from numerous holdings companies. Investment entities such as J. Safra Sarasin Holding AG, Wealth Management LLC, Burling Wealth Partners LLC and Freshford Capital Management LLC, among others, have been adjusting their position with the company, either buying shares or reducing their stake. The company was marked as appealing to hedge funds and held a **Buy** rating from analysts. However, its stock dropped 11% last week and despite posting excellent Q4 results, ZTS closed Q4 on a decline. Nevertheless, it remains a compelling opportunity for investors, with potential upside thanks to its strong fundamentals. However, there is caution ahead of its Q1 revenues as analysts hold a negative outlook, and in response to which the stock position was reduced by multiple entities. Yet the company's year-end outlook holds promise, as essays earn higher ratings than industry standards making it a favored stock among billionaires. ZTS has increased its position ahead of its 2025 Q1 results, with the hope that long-term growth reversal is predicted. The main concern rises from the company's minor decline alongside market improvement, although Q4 earnings were in line with expectations.
Zoetis ZTS News Analytics from Mon, 04 Nov 2024 08:00:00 GMT to Sat, 26 Apr 2025 17:28:43 GMT -
